INNOVATIL-01 Trademark

Trademark Overview

On Thursday, February 28, 2019, a trademark application was filed for INNOVATIL-01 with the United States Patent and Trademark Office. The USPTO has given the INNOVATIL-01 trademark a serial number of 88321081. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, November 26, 2019. This trademark is owned by Iovance Biotherapeutics, Inc.. The INNOVATIL-01 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

conducting clinical trials for others for research and the treatment of cancer and oncological diseases; providing medical and scientific research information related to clinical trials for the treatment of cancer and oncological diseases; medical evaluation services, namely, providing drug therapies and treatment programs for the treatment of cancer and oncological diseases, and providing assessments of treatment programs
innovatil-01

General Information

Serial Number88321081
Word MarkINNOVATIL-01
Filing DateThursday, February 28, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, November 26, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesconducting clinical trials for others for research and the treatment of cancer and oncological diseases; providing medical and scientific research information related to clinical trials for the treatment of cancer and oncological diseases; medical evaluation services, namely, providing drug therapies and treatment programs for the treatment of cancer and oncological diseases, and providing assessments of treatment programs
Pseudo MarkINNOVATIL-ZERO ONE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 26, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIovance Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Carlos, CA 94070

Trademark Events

Event DateEvent Description
Tuesday, November 26, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, November 26, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 15, 2019NON-FINAL ACTION E-MAILED
Wednesday, May 15, 2019NON-FINAL ACTION WRITTEN
Wednesday, May 8, 2019ASSIGNED TO EXAMINER
Tuesday, March 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 4, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

innovatil treatment oncological diseases providing cancer programs medical research trials clinical